BIOLOGICAL CLOCKS Clinical Trial
— SOMVIEOfficial title:
Aging,Sleep and Cognitive Process
Verified date | March 2011 |
Source | University Hospital, Bordeaux |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Interventional |
The aim of the study is to determine the impact of aging, circadian rhythms and sleep deprivation on executive performances. Volunteers will complete a 40-hour extended wakefulness period in constant condition (semi-recumbent posture in bed, constant dim light levels < 10 lux, food and liquid intake at regular intervals) in order to control the circadian system. The volunteers will not be allowed to sleep in the sleep deprivation protocol ("high sleep pressure protocol") and will adopt a short wakefulness/sleep cycle (150/75 minutes) in the multiple nap protocol ("low sleep pressure protocol"). Tests and scales will be repeated every 3H45
Status | Completed |
Enrollment | 28 |
Est. completion date | February 2011 |
Est. primary completion date | February 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 20 Years to 75 Years |
Eligibility |
Inclusion Criteria: - excessive daytime sleepiness (Epworth Sleepiness Scale score > 9), - sleep complaint such as sleep apnea or insomnia (Basic Nordic Sleep Questionnaire, items score < 4 except questions 3, 4 and 15a for aged volunteers), - not intermediate in terms of morningness and eveningness according to the Horne-Ostberg questionnaire for young volunteers - absence of psychopathology evidenced during psychologist interview or on the Symptom Check List (SCL-90R score>59) - sleep efficiency evidenced by actimetry (>85%) during 7 days - absence of apnea/hypopnea syndrome (RDI<15) - absence of periodic movement disorder (MPS<15) - regular sleep schedule during 3 days before study participation - affiliated to the french health care system Exclusion Criteria: - volunteers with sleep disorders or organic disorders affecting sleep, - poor sleep hygiene or abnormal usual sleep patterns, - night workers or shift-workers, - substance abusers (caffeine, drug, or alcohol). |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
France | Genpphass | Bordeaux | |
France | Medes-Imps | Toulouse | |
France | Uh Purpan | Toulouse |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Bordeaux |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Executive functions will be evaluated by a Go/NoGo task and a Stop Signal. Performances will be measured with a visual simple reaction time task | every 3h45 | No | |
Secondary | Nocturnal sleep quality before and after 2 constant conditions measured by PSG Sleep pressure quantified by Karolinska test and EEG delta band Subjective sleepiness and fatigue evaluated by Karolinska sleepiness scale and visual analogue scale | every 3h45 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03276442 -
Biorhythms in Metabolic Tissues
|
N/A |